1 drugs linked to major drop in pancreatic, colorectal cancer risk

Health

1 Drugs Linked To Major Drop In Pancreatic, Colorectal Cancer Risk

By Medical News Today

The use of glucagon-like peptide-1 (GLP-1) receptor agonist medications continues to rise, with a 155% increase in the percentage of people with type 2 diabetes taking these drugs from 2018 to 2022. The use of GLP-1s for weight loss is also increasin ...Read more

Related Posts

Novo Nordisk, Eli Lilly roll out obesity pills, prepare for Medicare coverage

Novo Nordisk, Eli Lilly roll out obesity pills, prepare for Medicare coverage

Jun 08, 2026
Mutation-dependent responses to sleep and exercise in clonal haematopoiesis

Mutation-dependent responses to sleep and exercise in clonal haematopoiesis

Jun 10, 2026
7 Benefits of The Keto Diet

7 Benefits of The Keto Diet

Dec 30, 2020
Tommy Fury vs. Eddie Hall Judges' Scorecards, Punch Stats and Prize Money

Tommy Fury vs. Eddie Hall Judges' Scorecards, Punch Stats and Prize Money

Jun 13, 2026
We use cookies to help provide you with the best experience when you visit our websites. By using this site you consent to the use of cookies on your device. see our cookie policy.